No Data
NVIDIA To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday
ANI Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
ANI Pharmaceuticals Analyst Ratings
H.C. Wainwright Maintains ANI Pharmaceuticals(ANIP.US) With Buy Rating, Raises Target Price to $94
H.C. Wainwright analyst Oren Livnat maintains $ANI Pharmaceuticals(ANIP.US)$ with a buy rating, and adjusts the target price from $87 to $94.According to TipRanks data, the analyst has a success rate
Express News | ANI Pharmaceuticals, Inc. : H.c. Wainwright Raises Target Price to $94 From $87
Alimera (ALIM) Rises on Merger Deal With ANI Pharmaceuticals